NIH modifies trial as ACE inhibitors slow renal disease in African Americans.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D044383:Black People; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000235:genetics / Q000517:prevention & control*; D007674:Kidney Diseases / Q000235:genetics / Q000517:prevention & control*; D012107:Research Design; D001741:Black or African American
D000806:Angiotensin-Converting Enzyme Inhibitors